Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02117310 · ClinicalTrials.gov registry record · NA
ICG Use in Angiography for Nasoseptal Flap Harvest
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02117310 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 5 participants.
The verdict
NCT02117310, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a feasibility study in which indocyanine green (ICG) will be administered during routine expanded endonasal approach (EEA) for cranial base pathologies in which a nasoseptal flap harvest will be necessary. The research entails administering ICG, which is already widely used during open neurosurgical procedures, to identify the blood supply at two distinct stages of endonasal cranial base surgery: during nasoseptal flap harvest and after final positioning of the nasoseptal flap to ensure its viability before ending the case.
Interventions
- DRUG indocyanine green
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02117310
The ClinicalTrials.gov registry entry for NCT02117310 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which indocyanine green is the first listed.
NCT02117310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02117310 about?
NCT02117310 is a clinical study titled "ICG Use in Angiography for Nasoseptal Flap Harvest". This is a feasibility study in which indocyanine green (ICG) will be administered during routine expanded endonasal approach (EEA) for cranial base pathologies in which a nasoseptal flap harvest will be necessary. The research entails administering ICG, which is already widely used during open neuro...
What is the current status of trial NCT02117310?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2015-03. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02117310?
The interventions under investigation include: indocyanine green (DRUG).
Who is sponsoring clinical trial NCT02117310?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.